These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The efficacy of cyclosporine A as salvage therapy for severe active ulcerative colitis refractory to glucocorticoid]. Li J; Wei MM; Fei GJ; Feng YL; Yang H; Li Y; Lyu G; Shu HJ; Qian JM Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):279-283. PubMed ID: 28355721 [No Abstract] [Full Text] [Related]
23. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). García MJ; Riestra S; Amiot A; Julsgaard M; García de la Filia I; Calafat M; Aguas M; de la Peña L; Roig C; Caballol B; Casanova MJ; Farkas K; Boysen T; Bujanda L; Cuarán C; Dobru D; Fousekis F; Gargallo-Puyuelo CJ; Savarino E; Calvet X; Huguet JM; Kupcinskas L; López-Cardona J; Raine T; van Oostrom J; Gisbert JP; Chaparro M Aliment Pharmacol Ther; 2024 May; 59(10):1248-1259. PubMed ID: 38445785 [TBL] [Abstract][Full Text] [Related]
24. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Moskovitz DN; Van Assche G; Maenhout B; Arts J; Ferrante M; Vermeire S; Rutgeerts P Clin Gastroenterol Hepatol; 2006 Jun; 4(6):760-5. PubMed ID: 16716758 [TBL] [Abstract][Full Text] [Related]
25. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab. Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Vuitton L; Moreau J; Amiot A; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Fumery M; Carbonnel F; Bommelaer G; Coffin B; Roblin X; van Assche G; Esteve M; Farkkila M; Gisbert JP; Marteau P; Nahon S; de Vos M; Lambert J; Mary JY; Louis E; Gut; 2018 Feb; 67(2):237-243. PubMed ID: 28053054 [TBL] [Abstract][Full Text] [Related]
26. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study. Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343 [TBL] [Abstract][Full Text] [Related]
27. Cyclosporine A for induction of remission in severe ulcerative colitis. Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937 [TBL] [Abstract][Full Text] [Related]
28. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M; Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316 [TBL] [Abstract][Full Text] [Related]
29. Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Barberio B; Black CJ; Savarino EV; Ford AC J Crohns Colitis; 2021 May; 15(5):733-741. PubMed ID: 33175102 [TBL] [Abstract][Full Text] [Related]
30. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis. Wenzl HH; Petritsch W; Aichbichler BW; Hinterleitner TA; Fleischmann G; Krejs GJ Z Gastroenterol; 1998 Apr; 36(4):287-93. PubMed ID: 9612926 [TBL] [Abstract][Full Text] [Related]
31. Long-term efficacy and safety of cyclosporine as a rescue therapy in acute, steroid-refractory severe ulcerative colitis: switching to infliximab is more effective than treating with concomitant immunomodulators. Molnár T; Farkas K; Nyári T; Szepes Z; Nagy F; Wittmann T J Clin Gastroenterol; 2011 Apr; 45(4):380-1. PubMed ID: 21278580 [No Abstract] [Full Text] [Related]
33. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients. Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study. Mocciaro F; Renna S; Orlando A; Rizzuto G; Sinagra E; Orlando E; Cottone M J Crohns Colitis; 2012 Jul; 6(6):681-6. PubMed ID: 22398101 [TBL] [Abstract][Full Text] [Related]
35. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis. Dean KE; Hikaka J; Huakau JT; Walmsley RS J Gastroenterol Hepatol; 2012 Mar; 27(3):487-92. PubMed ID: 22098019 [TBL] [Abstract][Full Text] [Related]
36. Current management of severe ulcerative colitis. Caprilli R; Viscido A; Latella G Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544 [TBL] [Abstract][Full Text] [Related]
37. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy. Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209 [TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis. Vedamurthy A; Xu L; Luther J; Colizzo F; Garber JJ; Khalili H; Ananthakrishnan AN Dig Dis Sci; 2018 Oct; 63(10):2740-2746. PubMed ID: 29951797 [TBL] [Abstract][Full Text] [Related]